With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

Discover how alternative investments are reshaping wealth management with insights on diversification, risk mitigation, and ...

In FY25, NTPC raised Rs 10,000 crore through an IPO. "Corporate is a bulky and chunky credit, and we had an unusual prepayment in that segment," SBI chairman C S Setty said during an analyst call.

and I'd like to invite Dr. Steve Kelsey to walk you through our current conceptual framework. Steve? Thanks, Mark. Improving treatment options for patients with RAS mutant lung cancer is an ...

high-profile private companies using their retirement dollars. "Our investor base has shown a strong appetite for pre-IPO opportunities," said Scott Harrigan, President of Alto. "Partnering with ...